OR WAIT null SECS
October 02, 2019
Research into peginterferon alfa-2b’s degradation pathways suggest that drug substance be immediately and continuously converted to drug product when the material is in liquid form.
October 01, 2019
High-throughput platforms can be used to develop tertiary phase diagrams, which can be leveraged to identify the most stable SEDDS formulations and excipients for lipid-based drug delivery systems.
Technological advancements can address the formulation and dissolution challenges of HPMC polymers.
In this article, the contents of a stimulus article produced by the joint subcommittee of the USP Expert Committees on Dosage Forms, Physical Analysis, and Excipients and relevant comments from a workshop session are summarized.
This article seeks to encourage continued dialogue among stakeholders to achieve consensus regarding excipient additives and processing aids.
September 23, 2019
FDA has approved Novo Nordisk’s Rybelsus (semaglutide), a glucagon-like peptide receptor protein treatment in oral tablet form for type 2 diabetes.
The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended the approval of AstraZeneca’s Qtrilmet (metformin hydrochloride, saxagliptin, and dapagliflozin) modified-release tablets for treating type-2 diabetes.
September 18, 2019
Colorcon Ventures looks to fund promising startups in drug manufacturing, delivery, and supply chain.
September 17, 2019
The companies have engaged in a manufacturing scale-up of LTX-03 tablets for clinical testing using LIMITx Technology.
September 02, 2019
In this interview, the main uses and benefits of NIR spectroscopy in tableting are discussed.